Helena Elding Larsson

8.8k total citations
173 papers, 5.0k citations indexed

About

Helena Elding Larsson is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Helena Elding Larsson has authored 173 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Genetics, 95 papers in Endocrinology, Diabetes and Metabolism and 88 papers in Surgery. Recurrent topics in Helena Elding Larsson's work include Diabetes and associated disorders (106 papers), Pancreatic function and diabetes (83 papers) and Diabetes Management and Research (82 papers). Helena Elding Larsson is often cited by papers focused on Diabetes and associated disorders (106 papers), Pancreatic function and diabetes (83 papers) and Diabetes Management and Research (82 papers). Helena Elding Larsson collaborates with scholars based in Sweden, United States and Germany. Helena Elding Larsson's co-authors include Bo Åhrén, Åke Lernmark, Lena Claesson‐Welsh, Ann‐Charlotte Eliasson, Takako Sasaki, Annelie Carlsson, Rupert Timpl, Erhard Hohenester, Jens J. Holst and Ulf Lindahl and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Helena Elding Larsson

167 papers receiving 4.9k citations

Peers

Helena Elding Larsson
Karsten Buschard Denmark
Salvatore Ulisse Italy
William L. Lowe United States
Sen Li China
Kazunori Shimada Japan
Brigitte Decallonne Belgium
Sander S. Rensen Netherlands
Joseph H. Vogelman∥ United States
Suzanne Lesage United States
Chris M.G. Thomas Netherlands
Karsten Buschard Denmark
Helena Elding Larsson
Citations per year, relative to Helena Elding Larsson Helena Elding Larsson (= 1×) peers Karsten Buschard

Countries citing papers authored by Helena Elding Larsson

Since Specialization
Citations

This map shows the geographic impact of Helena Elding Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Elding Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Elding Larsson more than expected).

Fields of papers citing papers by Helena Elding Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Elding Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Elding Larsson. The network helps show where Helena Elding Larsson may publish in the future.

Co-authorship network of co-authors of Helena Elding Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Elding Larsson. A scholar is included among the top collaborators of Helena Elding Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Elding Larsson. Helena Elding Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ott, Raffael, Jose Zapardiel‐Gonzalo, Kristina Casteels, et al.. (2025). Blood methylome signatures in children exposed to maternal type 1 diabetes are linked to protection against islet autoimmunity. Nature Metabolism. 7(11). 2236–2249.
3.
Teixeira, Pedro Filipe, Tadej Battelino, Annelie Carlsson, et al.. (2024). Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data. Diabetologia. 67(6). 985–994. 7 indexed citations
4.
Warncke, Katharina, Roy Tamura, Desmond Schatz, et al.. (2024). The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study. Journal of the Endocrine Society. 8(7). bvae103–bvae103.
5.
Shields, Beverley M., Kashyap Patel, Kevin Colclough, et al.. (2024). Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis. Scientific Reports. 14(1). 10589–10589. 3 indexed citations
6.
Haller, Michael J., Kirstine J. Bell, Rachel Besser, et al.. (2024). ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Hormone Research in Paediatrics. 97(6). 529–545. 18 indexed citations
7.
Melin, Jessica, Kristian Lynch, Markus Lundgren, et al.. (2023). Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance: the TEDDY study. European journal of medical research. 28(1). 592–592. 1 indexed citations
8.
Johnson, Suzanne Bennett, Roy Tamura, Kerry L. McIver, et al.. (2022). The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study. Pediatric Diabetes. 23(7). 1017–1026. 1 indexed citations
9.
Winkler, Christiane, Rachel Besser, Angela Hommel, et al.. (2022). The emotional well‐being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT ‐study. Pediatric Diabetes. 23(8). 1707–1716. 5 indexed citations
10.
Driscoll, Kimberly A., Roy Tamura, Suzanne Bennett Johnson, et al.. (2020). Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study. Pediatric Diabetes. 22(2). 360–368. 17 indexed citations
11.
Samuelsson, Kersti, Helena Elding Larsson, & Hans Tropp. (2020). A Wheelchair Ergometer With a Device for Isokinetic Torque Measurement. Journal of Rehabilitation Medicine. 21(4). 205–208.
12.
Ludvigsson, Johnny, Sri Ramulu Elluru, Per Leanderson, et al.. (2020). Combined Vitamin D, Ibuprofen and Glutamic Acid decarboxylase-alum Treatment in Recent Onset Type I Diabetes: Lessons from the DIABGAD Randomized Pilot Trial. Future Science OA. 6(7). FSO604–FSO604. 9 indexed citations
13.
Forsander, Gun, Helena Elding Larsson, Sten A. Ivarsson, et al.. (2020). Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes. Pediatric Diabetes. 22(3). 417–424. 7 indexed citations
14.
15.
Aydemir, Özkan, Janelle A. Noble, Jeffrey A. Bailey, et al.. (2019). Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes. Diabetes. 68(7). 1523–1527. 13 indexed citations
16.
Sims, Emily K., Susan Geyer, Suzanne Bennett Johnson, et al.. (2019). Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet’s Pathway to Prevention. Diabetes Care. 42(12). 2228–2236. 24 indexed citations
17.
18.
Lynch, Kristian, Hye‐Seung Lee, Carina Törn, et al.. (2017). Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies. Journal of Autoimmunity. 86. 93–103. 18 indexed citations
19.
Erlandsson, Anna, et al.. (2002). Extracellular signal-regulated protein kinase signaling is uncoupled from initial differentiation of central nervous system stem cells to neurons.. PubMed. 1(2). 147–54. 20 indexed citations
20.
Samuelsson, Kersti, et al.. (1989). A wheelchair ergometer with a device for isokinetic torque measurement. Journal of Rehabilitation Medicine. 21(4). 205–208. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karsten Buschard Breakdown of academic impact, for papers by Salvatore Ulisse Breakdown of academic impact, for papers by William L. Lowe Breakdown of academic impact, for papers by Sen Li Breakdown of academic impact, for papers by Kazunori Shimada Breakdown of academic impact, for papers by Brigitte Decallonne Breakdown of academic impact, for papers by Sander S. Rensen Breakdown of academic impact, for papers by Joseph H. Vogelman∥ Breakdown of academic impact, for papers by Suzanne Lesage Breakdown of academic impact, for papers by Chris M.G. Thomas
Rankless by CCL
2026